Companies: 10,795·Total market cap: $144.5T
United Therapeutics Corporation

United Therapeutics Corporation

UTHRNASDAQHealthcare● Active
$547.51
$-2.36(-0.43%)
Market Cap$23.2B
P/E Ratio
52W High$609.35
52W Low$272.12

United Therapeutics Corporation (UTHR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

UTHR · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $1.33B for FY2025 (fiscal year ending 2025-12-31), up 11.7% year-over-year. Net profit margin was 41.9%. Based on available data, United Therapeutics Corporation has been profitable since at least 2011.

FY2025 Net Income$1.33B▲ +11.7% YoY
Trailing 12M (TTM)$1.29Btrailing 4 quarters sum
Net Profit Margin41.9%$1.33B ÷ $3.18B
YoY Change+11.7%
5-Year CAGR+21.0%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · UTHR net income history · UTHR profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$1.33B▲ +11.7%41.9%
FY2024$1.20B▲ +21.4%41.5%
FY2023$984.8M▲ +35.4%42.3%
FY2022$727.3M▲ +52.9%37.6%
FY2021$475.8M▼ 7.6%28.2%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
United Therapeutics Corporation
United Therapeutics CorporationYOU
UTHR
$1.33B+11.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

United Therapeutics Corporation (UTHR) reported net income of $1.33B for FY2025 (fiscal year ending 2025-12-31), up 11.7% year-over-year. The net profit margin was 41.9% — meaning the company kept $0.42 of every dollar of revenue as profit.

Based on available data, United Therapeutics Corporation has been profitable since at least 2011. Net income reached a peak of $1.33B in FY2025. Data available for 15 fiscal years.

United Therapeutics Corporation's net profit margin was 41.9% for FY2025, based on the latest annual results.

Investors sometimes search for "United Therapeutics Corporation net worth" — the company's market capitalization is a separate figure from UTHR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

UTHR net income · 5 questions

United Therapeutics Corporation is profitable. The company reported net income of $1.33B for FY2025, a net profit margin of 41.9%. Net income was up 11.7% year-over-year. Based on available data, United Therapeutics Corporation has been profitable since at least 2011.

is UTHR profitabledoes UTHR make a profitUTHR profitabilityUTHR profitable company

Source: FMP /income-statement · GAAP · United Therapeutics Corporation · United Therapeutics Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026